340binformed.org

Your Free Source for 340B News and Commentary

  • About us
  • Advertise
  • Contact
  • 340B Health

Mylan EpiPen Settlement Provides for 340B Overcharging Claims

 

August 17, 2017—The U.S. Justice Department, CMS, and EpiPen manufacturer Mylan announced today that Mylan has reached a $465 million settlement with the government to resolve claims it knowingly misclassified EpiPen as a generic drug to avoid paying Medicaid drug rebates. Mylan said the settlement provides for “potential claims by certain hospitals and other covered … [Read more...]

Hospitals Oppose Delay of Federal Rule to Punish Prescription Drug Overcharging

 

August 17, 2017— 340B Health, the association of hospitals and health systems in the 340B drug discount program, strongly disagrees with the Trump administration’s proposal today to again delay – this time to July 1, 2018 – a long overdue regulation to punish drug manufacturers that illegally overcharge safety-net hospitals and other healthcare providers for lifesaving … [Read more...]

340B Database Going Offline From Aug. 15 Through Mid-September

 

August 9, 2017—Healthcare providers in the 340B drug discount program will not be able to submit 340B program change requests or terminations from Aug. 15 through mid-September as the Office of Pharmacy Affairs phases out its current 340B database and phases in the new 340B OPA Information System, 340B OPAIS. … [Read more...]

Administration Ditches 340B Dispute Resolution Rule and Mega-Guidance

 

July 27, 2017—As part of a government-wide deregulatory push, the Trump administration has ditched plans to publish dispute resolution regulations for the 340B drug discount program and to publish guidelines for much of the rest of the program. The head of the 340B program’s parent agency, however, recently told the hospital association 340B Health and members of the 340B … [Read more...]

From the Big Apple to Ohio Coal Country, 340B Helps Low-Income Cancer Patients

 

July 19, 2017 – The Center for Medicare and Medicaid Services’ proposal to slash 340B hospitals’ reimbursement for Medicare Part B drugs would punch a big hole in America’s healthcare safety net. Low-income seniors with cancer would be especially at risk. 340B disproportionate share hospitals treat 60 percent more such patients than non-340B hospitals and physician … [Read more...]

Slafsky: 340B “Punches Above its Weight”

 

July 17, 2017—As a House Energy & Commerce subcommittee prepares for an oversight hearing on the 340B drug discount program tomorrow, the head of the group that represents 340B hospitals is urging lawmakers to “protect this program so it continues to help hospitals serve their low-income and rural patients for years to come.” “The 340B program is more than a line item on … [Read more...]

Studies Confirm 340B Helps Hospitals Serve Low-Income and Rural Patients Without Raising Drug Prices

 

July 17, 2017 — More than $457 billion is spent on prescription drugs in America annually. Access to healthcare, however, remains a struggle for many Americans. The 340B drug discount program ensures that low-income, Medicaid, uninsured, and underinsured patients can get necessary treatment for medical conditions. These discounts cost taxpayers zero dollars. 340B lets America’s … [Read more...]

« Previous Page
Next Page »

LATEST ARTICLES DELIVERED

Get new article alerts via email.

This field is required.

Check your inbox or spam folder now to confirm your subscription.

FOLLOW | SHARE | LIKE

  • Facebook
  • LinkedIn
  • Twitter
  • YouTube

340B Health Twitter

Twitter feed is not available at the moment.

RSS feed: 340B Employed 340B Employed

  • 340B Program Compliance Analyst Certified | UNC Health November 17, 2026
  • 340B Program Compliance Analyst Certified | UNC Health November 17, 2026
  • 340B Program Specialist | Vail Health November 17, 2026
  • Pharmacy Manager, 340B Program | Tufts Medical Center November 11, 2026
  • 340B Program Pharmacy Manager | Allies for Health + Wellbeing November 10, 2026

Copyright © 2026 · 340B Health